共 299 条
[1]
Arrigo M(2014)Management of atrial fibrillation in critically ill patients Crit Care Res Prac 2014 688-2359
[2]
Bettex D(2014)Incidence, risk factors and outcomes of new-onset atrial fibrillation in patients with sepsis: a systematic review Crit Care 18 2354-23
[3]
Rudiger A(2015)Disappointing success of electrical cardioversion for new-onset atrial fibrillation in cardiosurgical ICU patients Crit Care Med 43 16-322
[4]
Kuipers S(2017)Propafenone for supraventricular arrhythmias in septic shock-Comparison to amiodarone and metoprolol J Crit Care 41 316-429
[5]
Klein Klouwenberg P(2020)Managing new-onset atrial fibrillation in critically ill patients: a systematic narrative review BMJ Open 10 419-498
[6]
Cremer OL(2015)Antiarrhythmic drug use in patients <65 years with atrial fibrillation and without structural heart disease Am J Cardiol 115 373-385
[7]
Arrigo M(2017)Management of arrhythmia in sepsis and septic shock Anaesthesiol Intensive Ther 49 375-2962
[8]
Jaeger N(2021)2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC Eur Heart J 42 2893-788
[9]
Seifert B(2022)Management of acute atrial fibrillation in the intensive care unit: an international survey Acta Anaesthesiol Scand 66 781-262
[10]
Spahn DR(2018)Which antiarrhythmic drug to choose after electrical cardioversion: a study on non-valvular atrial fibrillation patients PLoS ONE 13 255-205